https://www.selleckchem.com/pr....oducts/p5091-p005091
04). The difference between the groups disappeared from the third month. The central macular thickness was similar between the two groups at the last control treatment (407.27 ± 99.08 µm and 376.66 ± 74.71 µm, p=0.66). The best-corrected visual acuity increased significantly in both groups. No significant difference was found between the two groups in terms of the best-corrected visual acuities at baseline and the final control. The intravitreal aflibercept treatment was highly effective in improving best-corrected visual acuity a
Like
Comment
Share
